Label: RENAKARE- potassium gluconate tablet

  • NDC Code(s): 59051-9074-5
  • Packager: Neogen Corporation-Mercer
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated February 21, 2023

If you are a consumer or patient please visit this version.

View All Sections

  • RenaKare™

    Potassium Gluconate Tablets

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • USE IN SPECIFIC POPULATIONS

    FOR ANIMAL USE ONLY

    KEEP OUT OF REACH OF CHILDREN

  • Each tablet contains (minimum):

    Potassium gluconate.........2 mEq (468 mg)

  • Dosage:

    Adult cats and dogs...2 mEq/4.5 kg (1 tablet/10 lb) PO BID

    Kittens and puppies.............................consult veterinarian

    Administer with food. Dosage may be adjusted as necessary by the veterinarian.

  • STORAGE AND HANDLING

    Store in a dry place at a temperature between 15°-30°C (59°-86°F). Keep container tightly closed.

  • Warnings:

    May cause hyperkalemia. Do not exceed the recommended dose. Frequent patient monitoring is advised. Adverse effects include gastrointestinal irritation, muscular weakness, twitching, irritability, and cardiac conduction disturbances. Postassium salts are contraindicated in animals with hyperkalemia, severe renal impairment or failure, severe hemolytic reactions, Addison's disease, decreased gastrointestinal motility, and acute dehydration.

  • Precautions:

    Use with caution in animals receiving digoxin, potassium-sparing diuretics, ACE inhibitors, and NSAIDs.

  • Indications:

    For use as a potassium supplement in hypokalemic cats and dogs.

  • SPL UNCLASSIFIED SECTION

    Manufactured by: Neogen Corporation, Lexington, KY 40511

    859-254-1221 • neogen.com         L593-1222

    Made in the USA of U.S. and imported materials

    Item No. 09074

  • PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle

    NDC: 59051-9074-5

    RenaKare

    Potassium gluconate tablets

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents: 100 Tablets

    RenaKare Tablets

  • INGREDIENTS AND APPEARANCE
    RENAKARE 
    potassium gluconate tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9074
    Route of AdministrationOral
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POTASSIUM GLUCONATE (UNII: 12H3K5QKN9) (POTASSIUM CATION - UNII:295O53K152) POTASSIUM GLUCONATE468 mg
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59051-9074-5100 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/15/2013
    Labeler - Neogen Corporation-Mercer (042125879)
    Establishment
    NameAddressID/FEIBusiness Operations
    Neogen Corporation-Mercer042125879analysis, label, manufacture
    Establishment
    NameAddressID/FEIBusiness Operations
    Jungbunzlauer Ladenburg GmbH322121609api manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!